Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
999 999.9999
KRW
Market Closed
Market Cap:
₩82.3T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
Multiples-Based Value
The Multiples-Based Value of one
Samsung Biologics Co Ltd
stock under the Base Case scenario is
843 366.4285
KRW.
Compared to the current market price of 999 999.9999 KRW,
Samsung Biologics Co Ltd
is
Overvalued by 16%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
843 366.4285
KRW
Overvaluation 16%
Multiples Across Competitors
Competitors Multiples
Samsung Biologics Co Ltd Competitors
Samsung Biologics Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 359.1 | 4 252.2 | 1 218.3 | 2 346.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
194.1B USD | 4.4 | 29 | 20 | 26.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137B USD | 5.6 | 37.9 | 19.3 | 28 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.6B CHF | 5.5 | -130.8 | 17.7 | 27.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
318.8B CNY | 7 | 16.6 | 17.5 | 17.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.4B USD | 4.7 | 25.9 | 19 | 22.5 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.3B USD | 9.9 | 48.7 | 31.4 | 39.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.2B USD | 1.8 | 21.5 | 12 | 17.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.3B USD | 6.5 | 30.2 | 22.4 | 24.9 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
17.7B EUR | 6 | 66.7 | 22.5 | 35.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
